Senti Biosciences Holdings, Inc. (SNTI) Net income 2021–2025
Senti Biosciences Holdings, Inc. (SNTI) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$61.4MFY2025 · since FY2021: -$55.3M → -$61.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$61.4M | -16.4% |
| FY2024 | -$52.8M | +25.7% |
| FY2023 | -$71.1M | -22.1% |
| FY2022 | -$58.2M | -5.2% |
| FY2021 | -$55.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SNTI financial trends
SNTI RevenueSNTI Net marginSNTI Gross profitSNTI Gross marginSNTI Operating incomeSNTI Operating marginSNTI Operating cash flowSNTI Free cash flowSNTI Capital expendituresSNTI Return on equitySNTI Stock buybacksSNTI Dividends paidSNTI Total assetsSNTI Total liabilitiesSNTI Shareholders’ equitySNTI overview →